Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II Study of Vorinostat in Polycythaemia Vera and Essential Thrombocythaemia
2007-005306-49Phase 2Completed
- Sponsor
- Department of Haematology, Herlev Hospital, University of Copenhagen
- Start
- Jul 2008
- Modality
- Classical Binding Small Molecules → Small Molecules, Covalent Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of vorinostat in polycythemia vera (PV), thrombocythemia, myelofibrosis (MF), sponsored by Department of Haematology, Herlev Hospital, University of Copenhagen. Started Jul 2008; status: completed.
02
Drugs
vorinostat
03
Conditions
polycythemia vera (PV)thrombocythemiamyelofibrosis (MF)
Beyond the preview
Go deeper on 2007-005306-49.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005306-49.